INCR Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - InterCure Ltd - Alpha Spread
I

InterCure Ltd
NASDAQ:INCR

Watchlist Manager
InterCure Ltd
NASDAQ:INCR
Watchlist
Price: 1.86 USD Market Closed
Market Cap: 84.8m USD
Have any thoughts about
InterCure Ltd?
Write Note

Wall Street
Price Targets

INCR Price Targets Summary
InterCure Ltd

There are no price targets for INCR.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
InterCure Ltd Competitors:
Price Targets
MRK
Merck KGaA
15% Upside
4886
ASKA Pharmaceutical Holdings Co Ltd
14% Upside
008930
Hanmi Science Co Ltd
4% Downside
PFIZER
Pfizer Ltd
1% Downside
2348
Dawnrays Pharmaceutical (Holdings) Ltd
146% Upside
600535
Tasly Pharmaceutical Group Co Ltd
21% Upside
060590
CTC Bio Inc
260% Upside
SEQUENT
SeQuent Scientific Ltd
22% Downside

Revenue
Forecast

Revenue Estimate
InterCure Ltd

The compound annual growth rate of InterCure Ltd's revenue for the next 2 years is 14%.

N/A
Past Growth
14%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
InterCure Ltd

The compound annual growth rate of InterCure Ltd's operating income for the next 2 years is 24%.

N/A
Past Growth
24%
Estimated Growth
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
InterCure Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is INCR's stock price target?
Not Available

INCR doesn't have any price targets made by Wall Street professionals.

What is InterCure Ltd's Revenue forecast?
Projected CAGR
14%

The compound annual growth rate of InterCure Ltd's revenue for the next 2 years is 14%.

What is InterCure Ltd's Operating Income forecast?
Projected CAGR
24%

The compound annual growth rate of InterCure Ltd's operating income for the next 2 years is 24%.

Back to Top